Several reports have suggested the importance of the cGAS-STING axis in antitumor responses, rather than other nucleic acid-sensing receptor-mediated pathways, by bridging innate immune responses and tumor-specific T cell responses via the production of type I IFNs. The gene discussed is CGAS; the disease is neoplasm.